Industries > Pharma > Fractional Flow Reserve Market Report 2019-2029

Fractional Flow Reserve Market Report 2019-2029

Forecasts by Technology (Invasive Monitoring (Pressure Guidewires, FFR Measurement Systems), Non-Invasive Monitoring), by Application (Single-Vessel Diseases, Multi-Vessel Diseases) Plus Analysis of Leading Companies

PAGES: 127
PRODUCT CODE: PHA0633
SUBMARKET:

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0633 Category: Tag:

Leading companies featured in this report are Abbott, Koninklijke Philips N.V., Boston Scientific Corporation, Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc), Opsens, Heartflow, Inc., Siemens Healthineers, Pie Medical Imaging, Cathworks, and Medis Medical Imaging Systems Bv.

Fractional Flow Reserve Market Report 2019-2029, By Technology
– Invasive Monitoring
– Pressure Guidewires
– FFR Measurement Systems
– Non-Invasive Monitoring

Fractional Flow Reserve Market Report 2019-2029, By Application
– Single-Vessel Diseases
– Multi-Vessel Diseases

Fractional Flow Reserve Market Report 2019-2029, By Region
– North America
– Europe
– Asia Pacific
– Rest of the World

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Fractional Flow Reserve Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Fractional Flow Reserve Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories